ZA932312B - 3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them. - Google Patents
3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them.Info
- Publication number
- ZA932312B ZA932312B ZA932312A ZA932312A ZA932312B ZA 932312 B ZA932312 B ZA 932312B ZA 932312 A ZA932312 A ZA 932312A ZA 932312 A ZA932312 A ZA 932312A ZA 932312 B ZA932312 B ZA 932312B
- Authority
- ZA
- South Africa
- Prior art keywords
- tert
- butyl
- preparation
- compositions containing
- hydroxy flavones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9203861A FR2689127B1 (fr) | 1992-03-31 | 1992-03-31 | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA932312B true ZA932312B (en) | 1993-10-18 |
Family
ID=9428265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA932312A ZA932312B (en) | 1992-03-31 | 1993-03-31 | 3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them. |
Country Status (13)
Country | Link |
---|---|
US (2) | US5280024A (de) |
EP (1) | EP0564350B1 (de) |
JP (1) | JPH07119221B2 (de) |
AT (1) | ATE153022T1 (de) |
AU (1) | AU655106B2 (de) |
CA (1) | CA2092961A1 (de) |
DE (1) | DE69310602T2 (de) |
DK (1) | DK0564350T3 (de) |
ES (1) | ES2104090T3 (de) |
FR (1) | FR2689127B1 (de) |
GR (1) | GR3023938T3 (de) |
NZ (1) | NZ247287A (de) |
ZA (1) | ZA932312B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2689127B1 (fr) * | 1992-03-31 | 1994-05-06 | Adir Cie | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
WO1996031206A2 (en) * | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
DE19638515B4 (de) * | 1996-09-20 | 2004-01-15 | Grundig Car Intermedia System Gmbh | Verfahren und Vorrichtung zur Zuordnung von Nachrichten, insbesondere Verkehrsnachrichten |
FR2753969B1 (fr) * | 1996-09-27 | 1998-10-30 | Adir | Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
US6028088A (en) * | 1998-10-30 | 2000-02-22 | The University Of Mississippi | Flavonoid derivatives |
EP1127572A3 (de) * | 2000-02-25 | 2003-05-02 | Basf Aktiengesellschaft | Verwendung von Flavonen zur Behandlung von Cyclooxygenase-2 ermittelten Krankheiten |
FR2815033B1 (fr) | 2000-10-06 | 2003-09-05 | Negma Lab | Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique |
US6818668B2 (en) | 2002-04-12 | 2004-11-16 | Biotest Laboratories, Llc | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method |
GB0216371D0 (en) * | 2002-07-13 | 2002-08-21 | Rowett Res Inst The | Compounds |
DE10232595A1 (de) * | 2002-07-18 | 2004-02-05 | Merck Patent Gmbh | Lichtschutzmittel |
EP1838296B1 (de) | 2004-10-20 | 2012-08-08 | Resverlogix Corp. | Flavonoide und isoflavonoide zur vorbeugung und behandlung cardiovasculärer erkrankungen |
KR100729731B1 (ko) * | 2005-07-19 | 2007-06-20 | 건국대학교 산학협력단 | 사람 피부 세포의 세포사멸을 억제하는 활성을 갖는플라보노이드 |
EP2314295B1 (de) * | 2005-07-29 | 2015-01-28 | Resverlogix, Inc | Arzneimittel zur Prävention und Behandlung komplexer Erkrankungen und deren Freisetzung mittels einsetzbarer Medizinprodukte |
US8053440B2 (en) | 2007-02-01 | 2011-11-08 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular diseases |
PT2346837E (pt) | 2008-06-26 | 2015-04-02 | Resverlogix Corp | Métodos de preparação de derivados de quinazolinona |
ES2542835T3 (es) | 2009-01-08 | 2015-08-12 | Resverlogix Corporation | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
BRPI1009315B8 (pt) | 2009-03-18 | 2021-05-25 | Resverlogix Corp | composto anti-flamatórios e suas composições farmacêuticas |
TR201818390T4 (tr) | 2009-04-22 | 2019-01-21 | Resverlogix Corp | Yeni̇ anti̇-i̇nflamatuvar ajanlar |
GB201017315D0 (en) | 2010-10-13 | 2010-11-24 | Antoxis Ltd | Compound |
PL2773354T3 (pl) | 2011-11-01 | 2019-12-31 | Resverlogix Corp. | Doustna formulacja o natychmiastowym uwalnianiu dla podstawowych chinazolinów |
US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
CA2895905A1 (en) | 2012-12-21 | 2014-06-26 | Zenith Epigenetics Corp. | Novel heterocyclic compounds as bromodomain inhibitors |
US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1247909A (fr) * | 1955-11-02 | 1960-12-09 | Recordati Lab Farmacologico Dr | Procédé de préparation des dérivés d'hydroxychromones |
DE1054091B (de) * | 1958-05-30 | 1959-04-02 | Chemiewerk Homburg Ag | Verfahren zur Herstellung von N-substituierten 2-Phenyl-7-aminoalkoxy-chromonen |
DE1418516A1 (de) * | 1959-07-28 | 1968-12-05 | Klosa Dipl Chem Dr Josef | Verfahren zur Herstellung von Flavon-7-oxyessigsaeureamiden |
GB1250388A (de) * | 1968-11-27 | 1971-10-20 | ||
DE2029658A1 (de) * | 1970-06-16 | 1971-12-23 | Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof | 2 (4 Oxo-4H 1 benzopyran 7 yl) oxy isobutter saure Derivate und Verfahren zur Herstellung derselben |
US3816466A (en) * | 1971-12-22 | 1974-06-11 | Warner Lambert Co | Flavanoid ring systems |
JPH02214780A (ja) * | 1989-02-14 | 1990-08-27 | San Ei Chem Ind Ltd | アントシアン色素の安定化法 |
JPH035423A (ja) * | 1989-06-01 | 1991-01-11 | Ichimaru Pharcos Co Ltd | フラボノイド含有過酸化脂質生成抑制剤 |
DE69006502T2 (de) * | 1990-04-06 | 1994-05-19 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., Budapest | Verbessertes verfahren zur darstellung substituierter isoflavonderivate. |
DE4011187A1 (de) * | 1990-04-06 | 1991-10-10 | Hoechst Ag | Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte |
EP0558245A1 (de) * | 1992-02-25 | 1993-09-01 | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY | Heterobicyclische Verbindungen als Alpha-1-Adrenergene und 5HT1A-Rezeptor-Antagonisten |
FR2689127B1 (fr) * | 1992-03-31 | 1994-05-06 | Adir Cie | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
-
1992
- 1992-03-31 FR FR9203861A patent/FR2689127B1/fr not_active Expired - Fee Related
-
1993
- 1993-03-25 US US08/036,814 patent/US5280024A/en not_active Expired - Fee Related
- 1993-03-30 NZ NZ247287A patent/NZ247287A/en unknown
- 1993-03-30 ES ES93400811T patent/ES2104090T3/es not_active Expired - Lifetime
- 1993-03-30 CA CA002092961A patent/CA2092961A1/fr not_active Abandoned
- 1993-03-30 DE DE69310602T patent/DE69310602T2/de not_active Expired - Fee Related
- 1993-03-30 JP JP5072457A patent/JPH07119221B2/ja not_active Expired - Lifetime
- 1993-03-30 AT AT93400811T patent/ATE153022T1/de not_active IP Right Cessation
- 1993-03-30 AU AU35591/93A patent/AU655106B2/en not_active Ceased
- 1993-03-30 EP EP93400811A patent/EP0564350B1/de not_active Expired - Lifetime
- 1993-03-30 DK DK93400811.1T patent/DK0564350T3/da active
- 1993-03-31 ZA ZA932312A patent/ZA932312B/xx unknown
- 1993-08-18 US US08/108,333 patent/US5457103A/en not_active Expired - Fee Related
-
1997
- 1997-06-30 GR GR970401586T patent/GR3023938T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ247287A (en) | 1994-08-26 |
US5457103A (en) | 1995-10-10 |
JPH07119221B2 (ja) | 1995-12-20 |
GR3023938T3 (en) | 1997-09-30 |
ES2104090T3 (es) | 1997-10-01 |
JPH0625212A (ja) | 1994-02-01 |
DE69310602D1 (de) | 1997-06-19 |
EP0564350B1 (de) | 1997-05-14 |
DK0564350T3 (da) | 1997-12-15 |
AU655106B2 (en) | 1994-12-01 |
AU3559193A (en) | 1993-10-07 |
FR2689127A1 (fr) | 1993-10-01 |
ATE153022T1 (de) | 1997-05-15 |
FR2689127B1 (fr) | 1994-05-06 |
US5280024A (en) | 1994-01-18 |
CA2092961A1 (fr) | 1993-10-01 |
DE69310602T2 (de) | 1997-12-18 |
EP0564350A1 (de) | 1993-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA932312B (en) | 3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them. | |
AU580151B2 (en) | 9-(phosphonylmethoxyalkyl) adenines, the method of preparation and utilization thereof | |
GEP20022822B (en) | Process for Preparing Derivatives of the Taxoid Family | |
IL110804A (en) | Triphenyl- methylthiazolidine-2, 4-dione derivatives and processes utilizing the same | |
AU586691B2 (en) | Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them | |
IL98191A0 (en) | Process for the enantioselective preparation of phenylisoserine derivatives | |
AU6826887A (en) | 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates | |
HUT65533A (en) | Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical preparations containing them | |
HUT76060A (en) | A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
EP0196330A1 (de) | Verwendung von pyrrothinderivaten. | |
ZA906446B (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
DE3477003D1 (en) | Process for the preparation of 17-alpha-acyloxy-6-chloro-1-alpha,2-alpha-methylene-4,6-pregnadiene-3-20-diones | |
FR2681318B1 (de) | ||
EP0657412A4 (de) | ||
KR910000786A (ko) | 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도 | |
BG102081A (en) | New derivatives of 2-azabicyclo [2.2.1] heptane, their preparation and application | |
UA41309C2 (uk) | ПОХІДНІ 11-<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОТРИМАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ | |
GEP19970664B (en) | Acrylic acid derivatives and stereoisomers | |
CA2056979A1 (en) | Process for the preparation of ketone compounds | |
IT1244038B (it) | Processo per la preparazione di 1,4-benzodiazepin-2-tioni | |
MX9207565A (es) | Hidroxilacion. |